• Designed to reduce the operational burden that stands between physicians and their patients.
• Initial offering focuses on pre-surgery cataract education, with additional AI capabilities for ophthalmology planned over time.
• Brand agnostic and built to serve all eye care providers.

Bausch + Lomb Corporation (TSX:BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the creation of Orphia™, a new AI-powered digital health platform built on the belief that eye care providers should spend less time managing disconnected tools and technologies and more time caring for patients. The platform is brand agnostic and designed to serve all eye care providers, regardless of the products, devices or treatments they choose to use.

Orphia will operate under Digital Health Services, a newly created platform at Bausch + Lomb.